Nanocarriers : Promising Vehicle for Bioactive Drugs
スポンサーリンク
概要
- 論文の詳細を見る
Development of new delivery systems that deliver the potential drug specifically to the target site in order to meet the therapeutic needs of the patients at the required time and level remains the key challenge in the field of pharmaceutical biotechnology. Developments in this context to achieve desired goal has led to the evolution of the multidisciplinary field nanobiotechnology which involves the combination of two most promising technologies of 21st century-biotechnology and nanotechnology. Nanobiotechnology encompasses a wide array of different techniques to improve the delivery of biotech drugs, and nanoparticles offer the most suitable form whose properties can be tailored by chemical methods. This review highlights the different types of nanoparticulate delivery systems employed for biotech drugs in the field of molecular medicine with a short overlook at its applications and the probable associated drawbacks.
- 2006-09-01
著者
-
RAWAT Manju
Institute of Pharmacy, Pt Ravishankar Shukla University
-
SINGH Deependra
Institute of Pharmacy, Pt Ravishankar Shukla University
-
SARAF S.
Institute of Pharmacy, Pt Ravishankar Shukla University
-
SARAF Swarnlata
Institute of Pharmacy, Pt Ravishankar Shukla University
-
Rawat Manju
Institute Of Pharmacy Pt Ravishankar Shukla University
-
Rawat Manju
インド
-
Saraf Swarnlata
インド
-
Saraf Swarnlata
Institute Of Pharmacy Pt. Ravishankar Shukla University
-
Saraf S.
Institute Of Pharmacy Pt Ravishankar Shukla University
-
Singh Deependra
インド
-
Singh Deependra
Institute Of Pharmacy Pt Ravishankar Shukla University
-
Saraf Swarnlata
Institute Of Pharmacy Pt Ravishankar Shukla University
関連論文
- Lipid Carriers : A Versatile Delivery Vehicle for Proteins and Peptides
- Nanocarriers : Promising Vehicle for Bioactive Drugs
- Formulation Optimization of Gentamicin Loaded Eudragit RS100 Microspheres Using Factorial Design Study(Biopharmacy)
- Management of Benign Prostate Hyperplasia : An Overview of α-Adrenergic Antagonist
- Cubosomes : An Overview(Biopharmacy)